FICHE-YOUNG: FIrst-line treatment CHoicE in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer patients (MBC) <= 45 years old. A large observational multicenter cohort survival analysis

Affiliation auteurs!!!! Error affiliation !!!!
TitreFICHE-YOUNG: FIrst-line treatment CHoicE in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer patients (MBC) <= 45 years old. A large observational multicenter cohort survival analysis
Type de publicationJournal Article
Year of Publication2017
AuteursPistilli B., Lardy-Cleaud A., Jacquet E., Delaloge S., Cottu P., Debled M., Vanlemmens L., Leheurteur M., Divanon F., Goncalves A., Laurent C., Coudert B., Chamorey E., Campion L., Mouret-Reynier M-A., Breton M., Petit T., Simon G., Cailliot C., Bachelot T.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534